Rational design of human paraoxonase to design enhanced catalytic efficiency

合理设计人对氧磷酶以提高催化效率

基本信息

项目摘要

The toxic effects observed during episodes of chemical nerve agent exposure are primarily the result of the irreversible inhibition of acetylcholinesterases (AChEs). These enzymes play an important role in the regulation of neural signalling throughout the body. Inhibition of AChEs invariably leads to the deregulation of post-synaptic targets (i.e. heart, lungs, etc) and may lead to death. Human paraoxonase (HuPONI) is a serum protein capable of hydrolyzing these deadly toxins, however, its catalytic capacity must be optimized before it can be successfully used as a viable antidote to treat nerve agent poisoning. The objective of this application is the design and synthesis of HuPONI variants capable of detoxifying nerve agents before they can reach their physiological targets and exert a lethal effect. To do this we will define amino acid residues (in or near the active site of the enzyme) that may play a role in the breakdown of chemical nerve agents. By using rational design we will generate variants of the native HuPONI enzyme and test their capacity to catalyltically hydrolyze nerve agents such as tabun (GA), sarin (GB), soman, (GD), and VX. This will be accomplished by the examination of the alteration in the affinity of HuPONI for the nerve agents and / or actual enhancement of its machinery to break down these toxins. Aims 1 and 2 will address the most successful approach to functional expression of various mutant proteins. Based on the results obtained, aims 3 and 4 seek to refine our knowledge of the substrate specificity of this enzyme. We estimate that if the catalytic potential of HuPONI can be enhanced by at least 10-fold, it truly could be a viable anti-nerve agent drug.
化学神经剂暴露期间观察到的毒性作用主要是 对乙酰胆碱酯酶的不可逆转抑制(ACHES)。这些酶在 调节整个身体的神经信号传导。疼痛的抑制总是导致放松管制 后突触后靶标(即心脏,肺等),可能导致死亡。人抛物酶(Huponi)是 血清蛋白能够水解这些致命的毒素,但是,必须优化其催化能力 在成功地用作治疗神经毒剂中毒的可行解毒剂之前。这个目的 应用是能够在神经剂之前对神经剂进行排毒的设计和合成 可以达到其生理靶标并发挥致命作用。为此,我们将定义氨基酸残基 (在酶的活跃部位或附近)可能在化学神经剂的分解中起作用。经过 使用合理设计,我们将生成本机Huponi酶的变体,并测试其能力 细胞基水解神经剂,例如Tabun(GA),Sarin(GB),Soman,(GD)和VX。这将是 通过检查Huponi对神经药物和 /或 实际增强其机械以分解这些毒素。目标1和2将解决最多的问题 成功表达各种突变蛋白的功能表达方法。根据获得的结果,目标 3和4试图完善我们对该酶底物特异性的了解。我们估计如果 Huponi的催化潜力至少可以增强10倍,它确实可以是可行的抗神经药物 药品。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID E LENZ其他文献

DAVID E LENZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID E LENZ', 18)}}的其他基金

Center for Catalytic Bioscavenger Medical Defense Research - U54
催化生物清除剂医疗防御研究中心 - U54
  • 批准号:
    7920104
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Rational design of human paraoxonase to design enhanced catalytic efficiency
合理设计人对氧磷酶以提高催化效率
  • 批准号:
    7235226
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Center for Catalytic Bioscavenger Medical Defense Research - U54
催化生物清除剂医学防御研究中心 - U54
  • 批准号:
    7224613
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Center for Catalytic Bioscavenger Medical Defense Research - U54
催化生物清除剂医疗防御研究中心 - U54
  • 批准号:
    7692000
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Center for Catalytic Bioscavenger Medical Defense Research - U54
催化生物清除剂医疗防御研究中心 - U54
  • 批准号:
    7689889
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Center for Catalytic Bioscavenger Medical Defense Research - U54
催化生物清除剂医疗防御研究中心 - U54
  • 批准号:
    7295925
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Administration and management
行政和管理
  • 批准号:
    7235235
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Center for Catalytic Bioscavenger Medical Defense Research - U54
催化生物清除剂医疗防御研究中心 - U54
  • 批准号:
    7487885
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Rational design of human paraoxonase to design enhanced catalytic efficiency
合理设计人对氧磷酶以提高催化效率
  • 批准号:
    7487878
  • 财政年份:
  • 资助金额:
    $ 8.83万
  • 项目类别:
Rational design of human paraoxonase to design enhanced catalytic efficiency
合理设计人对氧磷酶以提高催化效率
  • 批准号:
    7689881
  • 财政年份:
  • 资助金额:
    $ 8.83万
  • 项目类别:

相似海外基金

Accelerated AChE Reactivator Design by Mechanistic Neutron Scattering Studies
通过机械中子散射研究加速乙酰胆碱酯酶再激活器设计
  • 批准号:
    8735548
  • 财政年份:
    2014
  • 资助金额:
    $ 8.83万
  • 项目类别:
Accelerated AChE Reactivator Design by Mechanistic Neutron Scattering Studies
通过机械中子散射研究加速乙酰胆碱酯酶再激活器设计
  • 批准号:
    9632884
  • 财政年份:
    2014
  • 资助金额:
    $ 8.83万
  • 项目类别:
Accelerated AChE Reactivator Design by Mechanistic Neutron Scattering Studies
通过机械中子散射研究加速乙酰胆碱酯酶再激活器设计
  • 批准号:
    8892277
  • 财政年份:
    2014
  • 资助金额:
    $ 8.83万
  • 项目类别:
Synthesis of methylating ligands that reactivate aged acetylcholinesterase
合成重新激活老化乙酰胆碱酯酶的甲基化配体
  • 批准号:
    8338451
  • 财政年份:
    2011
  • 资助金额:
    $ 8.83万
  • 项目类别:
Synthesis of methylating ligands that reactivate aged acetylcholinesterase
合成重新激活老化乙酰胆碱酯酶的甲基化配体
  • 批准号:
    8216466
  • 财政年份:
    2011
  • 资助金额:
    $ 8.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了